Northwire Canada EditionFriday, July 10, 2026
Northwire
NNX 0.035 +0.0% ABX 51.88 −0.7% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.75 +9.4% TUNG 1.74 +3.0% LGO 0.990 −4.8% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.49 +0.9% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.305 −4.7% DEX 0.390 +1.3% WMS 0.040 +0.0% NNX 0.035 +0.0% ABX 51.88 −0.7% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.75 +9.4% TUNG 1.74 +3.0% LGO 0.990 −4.8% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.49 +0.9% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.305 −4.7% DEX 0.390 +1.3% WMS 0.040 +0.0%
Regulatory Neutral

Comprehensive Healthcare Systems Engages E.F. Hutton to lead Potential U.S. Exchange Uplisting

CHS · Price

Executive Summary

  • Comprehensive Healthcare Systems Inc. (CHS) has engaged E.F. Hutton & Co. LLC to provide strategic financial advisory services, including evaluating financing alternatives and preparing for a potential uplisting to a senior U.S. national securities exchange.
  • The advisory engagement supports CHS's broader strategic roadmap focused on accelerating U.S. market growth, expanding AI capabilities, pursuing strategic acquisitions, and enhancing shareholder value.
  • Management believes a U.S. exchange listing will broaden investor access and facilitate growth capital for platform development and sales expansion, though the company notes no assurance that the uplisting or any financing will be completed.

Key Details

  • Engagement of E.F. Hutton & Co. LLC as strategic financial advisor.
  • Advisory scope includes evaluating financing alternatives, capital markets strategy, and preparations for a potential uplisting to a senior U.S. national securities exchange.
  • Uplisting and any related financing remain subject to applicable listing requirements, market conditions, regulatory approvals, exchange requirements, and Board of Directors approval.
  • Strategic context aligns with the CEO shareholder letter dated April 13, 2026, which outlines a roadmap for U.S. expansion, AI investment, and strategic acquisitions.
  • Potential capital access will support continued investments in the Novus 360 platform, artificial intelligence initiatives, sales expansion, product development, and potential strategic acquisitions in the healthcare administration market.
  • Company operates as a vertically integrated SaaS provider focused on healthcare benefits administration via the Novus 360 HWBA platform, with 100% of revenue generated in the United States.

Notable Quotes

  • Chris Cosgrove, CEO: "With 100% of our revenue generated in the United States, we believe a potential uplisting to a senior U.S. exchange is a logical evolution for Comprehensive Healthcare Systems... E.F. Hutton brings substantial capital markets expertise and a strong track record advising growth companies, making them an ideal partner as we evaluate financing opportunities and pursue our long-term strategic objectives."
  • Chris Cosgrove, CEO: "We believe our recent growth momentum, including major customer wins and increasing scale across our healthcare benefits administration platform, has positioned CHS for its next phase of development... We look forward to working with E.F. Hutton as we seek to strengthen our capital structure, enhance our visibility within the U.S. investment community, and create long-term value for shareholders."
Read the original news release →

More from Comprehensive Healthcare Systems Inc.